Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Top-line Results From MaGic, a Phase Two Trial of Claseprubart (DNTH103), an Active C1s Inhibitor, in Generalized Myasthenia Gravis

Author:Peric, Stojan   Narayanaswami, Puspha   Smilowski, Marek   Slowik, Agnieszka   Gokhale, Sankalp   Briggs, Caitlin   Siddiqui, Uzma   Randhawa, Simrat   Truman, Matt   Hickey, Luke   Shelly, Shahar   Vu, Tuan   Vissing, John   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.007  

Author Institution:University of Belgrade, Belgrade, Serbia  Beth Israel Deaconess Medical Center/Harvard Medical School, MA  Neurologia Slaska Centrum Medyczne, Poland  University Hospital, Krakow, Poland  Dianthus Therapeutics, NY  Rambam Medical Center, Israel  University of South Florida, Tampa, FL  University of Copenhagen, Denmark  

Proximal Complement Inhibition in Generalized Myasthenia Gravis

Author:Shelley, Shahar   Lalla, Marianna   Zhao, Yang   Rehaume, Linda   Cross, Jennifer   Vu, Tuan   

Session Name:P4: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P4.002  

Author Institution:Rambam Health Care Campus, Israel  Dianthus Therapeutics, NY  University of South Florida, Tampa, FL